Last reviewed · How we verify
NCT03376906
The Effects of High Intensity Interval Exercise in Obese
NA trial testing HIIE 1 in Obesity in 12 participants. Completed in 30 January 2017.
20 December 2016
Quick facts
| Lead sponsor | Federal University of Paraíba |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 12 |
| Start date | 5 June 2016 |
| Primary completion | 20 December 2016 |
| Estimated completion | 30 January 2017 |
Drugs / interventions tested
- HIIE 1
- HIIE 3
- Control
Conditions studied
- Obesity — all drugs for Obesity →
- Endothelial Dysfunction — all drugs for Endothelial Dysfunction →
Sponsor
Federal University of Paraíba
Who can join
Adults 18 to 40, any sex, with Obesity or Endothelial Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Obesity is a complex and multifactorial disease. Excess weight is related to endothelial dysfunction, inflammation and oxidative stress which increases the risk for cardiovascular diseases. High-intensity interval exercise can release vasodilatory substances and promote increased muscle blood flow.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03376906
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Federal University of Paraíba trials
Trials by the same sponsor.
- NCT07192003 — Immediate Effects of Flossband and Mobilization With Movement on Shoulder Mobility in Volleyball Athletes · NA · not yet recruiting
- NCT06827379 — Acute Effects of Inspiratory Muscle Training on Peripheral Muscle Metabolism and Autonomic Response in COPD Patients · NA · enrolling by invitation
- NCT06542666 — Cognitive Functional Therapy for Chronic Shoulder Pain: Pilot and Feasibility Study · NA · recruiting
- NCT06661681 — Cognitive Functional Therapy for Treating Individuals With Chronic Shoulder Pain · NA · recruiting
- NCT06384027 — Effects of Non-invasive Ventilation on Function Diaphragmatic and Caval Distension · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03376906 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Federal University of Paraíba
- Last refreshed: 19 December 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03376906.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing